MADRIGAL PHARMACEUTICALS, INC. (MDGL) Free cash flow 2016–2025
MADRIGAL PHARMACEUTICALS, INC. (MDGL) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$190.0MFY2025 · since FY2016: -$17.6M → -$190.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$190.0M | +58.4% |
| FY2024 | -$457.0M | -40.3% |
| FY2023 | -$325.7M | -44.7% |
| FY2022 | -$225.1M | -22.2% |
| FY2021 | -$184.1M | -16.6% |
| FY2020 | -$157.9M | -277.8% |
| FY2019 | -$41.8M | -63.7% |
| FY2018 | -$25.5M | -13.8% |
| FY2017 | -$22.4M | -27.4% |
| FY2016 | -$17.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice